Literature DB >> 11549668

The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome.

A G Comuzzie1, T Funahashi, G Sonnenberg, L J Martin, H J Jacob, A E Black, D Maas, M Takahashi, S Kihara, S Tanaka, Y Matsuzawa, J Blangero, D Cohen, A Kissebah.   

Abstract

Here we present the first genetic analysis of adiponectin levels, a newly identified adipocyte-derived protein. Recent work has suggested that adiponectin may play a role in mediating the effects of body weight as a risk factor for coronary artery disease. For this analysis we assayed serum levels of adiponectin in 1100 adults of predominantly northern European ancestry distributed across 170 families. Quantitative genetic analysis of adiponectin levels detected an additive genetic heritability of 46%. The maximum LOD score detected in a genome wide scan for adiponectin levels was 4.06 (P = 7.7 x 10(-6)), 35 cM from pter on chromosome 5. The second largest LOD score (LOD = 3.2; P = 6.2 x 10(-5)) was detected on chromosome 14, 29 cM from pter. The detection of a significant linkage with a quantitative trait locus on chromosome 5 provides strong evidence for a replication of a previously reported quantitative trait locus for obesity-related phenotypes. In addition, several secondary signals offer potential evidence of replications for additional previously reported obesity-related quantitative trait loci on chromosomes 2 and 10. Not only do these results identify quantitative trait loci with significant effects on a newly described, and potentially very important, adipocyte-derived protein, they also reveal the emergence of a consistent pattern of linkage results for obesity-related traits across a number of human populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549668     DOI: 10.1210/jcem.86.9.7878

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  84 in total

Review 1.  Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  L Y Han; Q H Wu; M L Jiao; Y H Hao; L B Liang; L J Gao; D G Legge; H Quan; M M Zhao; N Ning; Z Kang; H Sun
Journal:  Diabetologia       Date:  2011-06-03       Impact factor: 10.122

Review 2.  Pharmacogenetics of antipsychotic-induced weight gain.

Authors:  Christoph U Correll; Anil K Malhotra
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

3.  Hierarchical clustering analysis of blood plasma lipidomics profiles from mono- and dizygotic twin families.

Authors:  Harmen H M Draisma; Theo H Reijmers; Jacqueline J Meulman; Jan van der Greef; Thomas Hankemeier; Dorret I Boomsma
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

4.  Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males.

Authors:  F F M Fisher; M E Trujillo; W Hanif; A H Barnett; P G McTernan; P E Scherer; S Kumar
Journal:  Diabetologia       Date:  2005-05-19       Impact factor: 10.122

5.  Genetic determination of adiponectin and its relationship with body fat topography in multigenerational families of African heritage.

Authors:  Iva Miljkovic-Gacic; Xiaojing Wang; Candace M Kammerer; Clareann H Bunker; Victor W Wheeler; Alan L Patrick; Lewis H Kuller; Rhobert W Evans; Joseph M Zmuda
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

6.  Estimating the contributions of rare and common genetic variations and clinical measures to a model trait: adiponectin.

Authors:  S Sandy An; Nicholette D Palmer; Anthony J G Hanley; Julie T Ziegler; W Mark Brown; Steven M Haffner; Jill M Norris; Jerome I Rotter; Xiuqing Guo; Y-D Ida Chen; Lynne E Wagenknecht; Carl D Langefeld; Donald W Bowden
Journal:  Genet Epidemiol       Date:  2012-10-02       Impact factor: 2.135

7.  ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study.

Authors:  Daruneewan Warodomwichit; Jian Shen; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; James M Peacock; James E Hixson; Robert J Straka; Michael A Province; Ping An; Chao-Qiang Lai; Laurence D Parnell; Ingrid B Borecki; Jose M Ordovas
Journal:  Obesity (Silver Spring)       Date:  2008-12-18       Impact factor: 5.002

8.  Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals.

Authors:  Iris M Heid; Peter Henneman; Andrew Hicks; Stefan Coassin; Thomas Winkler; Yurii S Aulchenko; Christian Fuchsberger; Kijoung Song; Marie-France Hivert; Dawn M Waterworth; Nicholas J Timpson; J Brent Richards; John R B Perry; Toshiko Tanaka; Najaf Amin; Barbara Kollerits; Irene Pichler; Ben A Oostra; Barbara Thorand; Rune R Frants; Thomas Illig; Josée Dupuis; Beate Glaser; Tim Spector; Jack Guralnik; Josephine M Egan; Jose C Florez; David M Evans; Nicole Soranzo; Stefania Bandinelli; Olga D Carlson; Timothy M Frayling; Keith Burling; George Davey Smith; Vincent Mooser; Luigi Ferrucci; James B Meigs; Peter Vollenweider; Ko Willems van Dijk; Peter Pramstaller; Florian Kronenberg; Cornelia M van Duijn
Journal:  Atherosclerosis       Date:  2009-12-02       Impact factor: 5.162

9.  Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent.

Authors:  Yi Zhang; Gabriele E Sonnenberg; Tesfaye Mersha Baye; Jack Littrell; Jennifer Gunnell; Ann DeLaForest; Erin MacKinney; Cecilia J Hillard; Ahmed H Kissebah; Michael Olivier; Russell A Wilke
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

10.  Plasma adiponectin complexes have distinct biochemical characteristics.

Authors:  Todd Schraw; Zhao V Wang; Nils Halberg; Meredith Hawkins; Philipp E Scherer
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.